0001415889-24-003448.txt : 20240212
0001415889-24-003448.hdr.sgml : 20240212
20240212194631
ACCESSION NUMBER: 0001415889-24-003448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heery Christopher
CENTRAL INDEX KEY: 0001789632
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41259
FILM NUMBER: 24622129
MAIL ADDRESS:
STREET 1: C/O PRECISION BIOSCIENCES, INC.
STREET 2: 302 E. PETTIGREW STREET, SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcellx, Inc.
CENTRAL INDEX KEY: 0001786205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472855917
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 240-327-0603
MAIL ADDRESS:
STREET 1: 800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
form4-02132024_120223.xml
X0508
4
2024-02-08
0001786205
Arcellx, Inc.
ACLX
0001789632
Heery Christopher
C/O ARCELLX, INC.
800 BRIDGE PARKWAY
REDWOOD CITY
CA
94065
false
true
false
false
CHIEF MEDICAL OFFICER
0
Common Stock
2024-02-08
4
S
0
3456
62.2945
D
36958
D
Common Stock
2024-02-09
4
S
0
3688
63.3977
D
33270
D
Common Stock
2024-02-12
4
S
0
2967
64.4595
D
30303
D
Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices that were not available from the broker at the time of filing. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
/s/ Michelle Gilson, as Attorney-in-Fact
2024-02-12